MedTrace Logo

Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa

NCT00138047 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2005-12-05

No results posted yet for this study

Summary

The goal of the study is to rule out a harmful effect of zinc supplementation in HIV-1-infected children. The null hypothesis is that zinc supplementation will increase plasma HIV RNA levels.

Conditions

  • HIV Infections

Interventions

DRUG

zinc supplementation

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • University of KwaZulu

    collaborator OTHER

  • Grey's Hospital

    collaborator OTHER

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • William J Moss, MD, MPH · Johns Hopkins Bloomberg School of Public Health

  • Robert E Black, MD, MPH · Johns Hopkins Bloomberg School of Public Health

  • Raziya Bobat, MBChB, MD · Nelson R Mandela School of Medicine, University of KwaZulu-Natal

  • Hoosen Coovadia, MD, MBBS · Doris Duke Medical Research Institute, University of KwaZulu-Natal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
60 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2004-09-30

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00138047 on ClinicalTrials.gov